Savara Pharmaceuticals
SVRA
#6616
Rank
S$0.74 B
Marketcap
$4.35
Share price
-1.23%
Change (1 day)
-29.08%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of September 2024 : S$0.29 Billion

According to Savara Pharmaceuticals's latest financial reports the company has S$0.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.21 B27.04%
2022-12-31S$0.16 B-22.55%
2021-12-31S$0.21 B100.39%
2020-12-31S$0.10 B-33.76%
2019-12-31S$0.16 B8.42%
2018-12-31S$0.15 B20.03%
2017-12-31S$0.12 B551.75%
2016-12-31S$19.35 M-66.61%
2015-12-31S$57.96 M-23.42%
2014-12-31S$75.69 M34.59%
2013-12-31S$56.24 M25.97%
2012-12-31S$44.64 M-32%
2011-12-31S$65.66 M82.2%
2010-12-31S$36.04 M196.18%
2009-12-31S$12.16 M-13.62%
2008-12-31S$14.08 M-70.75%
2007-12-31S$48.15 M-39.31%
2006-12-31S$79.34 M110.93%
2005-12-31S$37.61 M76.93%
2004-12-31S$21.26 M196.09%
2003-12-31S$7.18 M3881.93%
2002-12-31S$0.18 M-40.77%
2001-12-31S$0.3 M-88.16%
2000-12-31S$2.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$22.13 M-92.53%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.54 B 85.20%๐Ÿ‡บ๐Ÿ‡ธ USA